Elahere is first new drug for chemotherapy-resistant ovarian cancer to be approved by NHS for 20 yea...
Life-prolonging drug for advanced ovarian cancer gets go-ahead in England
Elahere is first new drug for chemotherapy-resistant ovarian cancer to be approved by NHS for 20 years.
Author: The Guardian
Read Original Article